Icahn School of Medicine at Mount Sinai, Department of Oncological Sciences, New York, NY, USA; Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA; Icahn School of Medicine at Mount Sinai, The Graduate School of Biomedical Sciences, New York, NY, USA.
Bioessays. 2014 Jan;36(1):46-51. doi: 10.1002/bies.201300117. Epub 2013 Oct 24.
Understanding the impact of the p53 tumor suppressor pathway on the regulation of genome integrity, cancer development, and cancer treatment has intrigued scientists and clinicians for decades. It appears that the p53 pathway is a central node for nearly all cell stress responses, including: gene expression, DNA repair, cell cycle arrest, metabolic adjustments, apoptosis, and senescence. In the past decade, it has become increasingly clear that p53 function is directly regulated by poly(ADP-ribose) polymerase-1 (PARP-1), a nuclear enzyme involved in DNA repair signaling. Here, we will discuss the impact of PARP-1 on p53 function, along with a recently described novel role for the reciprocal regulation of p53 regulated, PARP-1 dependent necrosis following DNA damage.
几十年来,科学家和临床医生一直对 p53 肿瘤抑制途径对基因组完整性、癌症发展和癌症治疗的调节的影响感到好奇。p53 途径似乎是几乎所有细胞应激反应的中心节点,包括:基因表达、DNA 修复、细胞周期停滞、代谢调整、细胞凋亡和衰老。在过去的十年中,越来越清楚的是,p53 功能直接受到聚(ADP-核糖)聚合酶 1(PARP-1)的调节,PARP-1 是一种参与 DNA 修复信号的核酶。在这里,我们将讨论 PARP-1 对 p53 功能的影响,以及最近描述的 p53 调节的、PARP-1 依赖性坏死的新作用,这种作用发生在 DNA 损伤之后。